211 related articles for article (PubMed ID: 30983127)
1. NF-κB p65 promotes ovarian cancer cell proliferation and migration via regulating mortalin.
Li S; Lv M; Qiu S; Meng J; Liu W; Zuo J; Yang L
J Cell Mol Med; 2019 Jun; 23(6):4338-4348. PubMed ID: 30983127
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic role of mortalin contributes to ovarian tumorigenesis by activating the MAPK-ERK pathway.
Hu Y; Yang L; Yang Y; Han Y; Wang Y; Liu W; Zuo J
J Cell Mol Med; 2016 Nov; 20(11):2111-2121. PubMed ID: 27374312
[TBL] [Abstract][Full Text] [Related]
3. Mortalin promotes breast cancer malignancy.
Zhang R; Meng Z; Wu X; Zhang M; Zhang S; Jin T
Exp Mol Pathol; 2021 Feb; 118():104593. PubMed ID: 33309613
[TBL] [Abstract][Full Text] [Related]
4. TGR5 promotes cholangiocarcinoma by interacting with mortalin.
Li AD; Xie XL; Qi W; Wang WB; Ma JJ; Zhao DQ; Jiang XY; Chen L; Bai Y; Jiang HQ
Exp Cell Res; 2020 Apr; 389(2):111855. PubMed ID: 31978385
[TBL] [Abstract][Full Text] [Related]
5. Mortalin is a distinct bio-marker and prognostic factor in serous ovarian carcinoma.
Xu M; Jin T; Chen L; Zhang X; Zhu G; Wang Q; Lin Z
Gene; 2019 May; 696():63-71. PubMed ID: 30776464
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor PDCD4 inhibits NF-κB-dependent transcription in human glioblastoma cells by direct interaction with p65.
Hwang SK; Baker AR; Young MR; Colburn NH
Carcinogenesis; 2014 Jul; 35(7):1469-80. PubMed ID: 24413684
[TBL] [Abstract][Full Text] [Related]
7. STC1 promotes cell apoptosis via NF-κB phospho-P65 Ser536 in cervical cancer cells.
Pan X; Jiang B; Liu J; Ding J; Li Y; Sun R; Peng L; Qin C; Fang S; Li G
Oncotarget; 2017 Jul; 8(28):46249-46261. PubMed ID: 28545028
[TBL] [Abstract][Full Text] [Related]
8. Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells.
Starenki D; Hong SK; Lloyd RV; Park JI
Oncogene; 2015 Aug; 34(35):4624-34. PubMed ID: 25435367
[TBL] [Abstract][Full Text] [Related]
9. Galectin-3 activates TLR4/NF-κB signaling to promote lung adenocarcinoma cell proliferation through activating lncRNA-NEAT1 expression.
Zhou W; Chen X; Hu Q; Chen X; Chen Y; Huang L
BMC Cancer; 2018 May; 18(1):580. PubMed ID: 29788922
[TBL] [Abstract][Full Text] [Related]
10. Propofol inhibits invasion and growth of ovarian cancer cells via regulating miR-9/NF-κB signal.
Huang X; Teng Y; Yang H; Ma J
Braz J Med Biol Res; 2016 Dec; 49(12):e5717. PubMed ID: 27982283
[TBL] [Abstract][Full Text] [Related]
11. A Regulatory Loop Involving miR-200c and NF-κB Modulates Mortalin Expression and Increases Cisplatin Sensitivity in an Ovarian Cancer Cell Line Model.
Huang X; Yan Y; Gui A; Zhu S; Qiu S; Chen F; Liu W; Zuo J; Yang L
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499626
[TBL] [Abstract][Full Text] [Related]
12. P76RBE silencing inhibits ovarian cancer cell proliferation, migration, and invasion via suppressing the integrin β1/NF-κB pathway.
Yan L; He Z; Li W; Liu N; Gao S
Cell Cycle; 2021 Sep; 20(18):1875-1889. PubMed ID: 34382920
[TBL] [Abstract][Full Text] [Related]
13. A negative feedback loop between miR-200b and the nuclear factor-κB pathway via IKBKB/IKK-β in breast cancer cells.
Wu H; Wang G; Wang Z; An S; Ye P; Luo S
FEBS J; 2016 Jun; 283(12):2259-71. PubMed ID: 26433127
[TBL] [Abstract][Full Text] [Related]
14. NF-κB potentiates tumor growth by suppressing a novel target LPTS.
Liu D; Miao H; Zhao Y; Kang X; Shang S; Xiang W; Shi R; Hou A; Wang R; Zhao K; Liu Y; Ma Y; Luo H; Miao H; He F
Cell Commun Signal; 2017 Oct; 15(1):39. PubMed ID: 29017500
[TBL] [Abstract][Full Text] [Related]
15. Expression of classical NF-kappaB pathway effectors in human ovarian carcinoma.
Darb-Esfahani S; Sinn BV; Weichert W; Budczies J; Lehmann A; Noske A; Buckendahl AC; Müller BM; Sehouli J; Koensgen D; Györffy B; Dietel M; Denkert C
Histopathology; 2010 May; 56(6):727-39. PubMed ID: 20546338
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-7 as a potential therapeutic target for aberrant NF-κB-driven distant metastasis of gastric cancer.
Ye T; Yang M; Huang D; Wang X; Xue B; Tian N; Xu X; Bao L; Hu H; Lv T; Huang Y
J Exp Clin Cancer Res; 2019 Feb; 38(1):55. PubMed ID: 30728051
[TBL] [Abstract][Full Text] [Related]
17. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
[TBL] [Abstract][Full Text] [Related]
18. [NF-kappaB subunit p65/RelA expression in ovarian carcinoma: prognostic impact and link to COX-2 overexpression].
Niesporek S; Weichert W; Sinn B; Röske A; Noske A; Buckendahl AC; Wirtz R; Sehouli J; Koensgen D; Dietel M; Denkert C
Verh Dtsch Ges Pathol; 2007; 91():243-9. PubMed ID: 18314621
[TBL] [Abstract][Full Text] [Related]
19. Strong cytoplasmic expression of NF-κB/p65 correlates with a good prognosis in patients with triple-negative breast cancer.
Baba M; Takahashi M; Yamashiro K; Yokoo H; Fukai M; Sato M; Hosoda M; Kamiyama T; Taketomi A; Yamashita H
Surg Today; 2016 Jul; 46(7):843-51. PubMed ID: 26494004
[TBL] [Abstract][Full Text] [Related]
20. β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells.
Cianfrocca R; Tocci P; Semprucci E; Spinella F; Di Castro V; Bagnato A; Rosanò L
Life Sci; 2014 Nov; 118(2):179-84. PubMed ID: 24530737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
